Skip to content
Recall Observatory FDA recall evidence

Drug product

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1

D-0972-2020

January 15, 2020

Class II

Product summary

Firm
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Event
Event 84978
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0972-2020

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #: 03202019+51817, Exp 4/16/2020; 09122019+52911, Exp 10/9/2020; 09132019+52918, Exp 8/12/2020

Distribution pattern: U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility